Print

IPCAVD006

A Phase I Study of Modified Vaccinia Ankara With Mosaic HIV Inserts in Healthy, HIV-Uninfected Adults, Some of Whom Have Previously Received an Adenovirus Type 26 ENVA.01 Vaccine

Trial Details:

I Completed
US Military HIV Research Program; National Institute of Allergy and Infectious Diseases (NIAID) Beth Israel Deaconess Medical Center
MVA mosaic gag/pol/env mosaics
MVA mosaic Viral Vector - Pox
USA 40
NCT02218125
https://www.clinicaltrials.gov/ct2/show/NCT02218125?term=ipcavd006&rank=1